Veraxa Biotech Holding AG (VRXAW) Change in Accured Expenses (2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Change in Accured Expenses of $22521.1 for Q4 2025.
Veraxa Biotech Holding AG (VRXAW) Change in Accured Expenses (2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Change in Accured Expenses for 1 consecutive years, with $22521.1 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,521.06 |
| Dec 31, 2025 | 22,521.06 |